• Wedbush Reiterates "Neutral" Rating for Intellia Therapeutics (NASDAQ:NTLA)

    Source: Buzz FX / 10 Jan 2025 19:41:14   America/Chicago


    Wedbush Reiterates "Neutral" Rating for Intellia Therapeutics (NASDAQ:NTLA) Written by MarketBeat January 10, 2025 Share Link copied to clipboard. Intellia Therapeutics ( NASDAQ:NTLA - Get Free Report ) 's stock had its "neutral" rating rei
    Read more...
Share on,